Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2648-2656

  Hu, Jun ^a   Wang, Shuwei ^a   Zhao, Yan ^a   Guo, Qinhao ^a   Zhang, Dongsheng ^a   Chen, Jiejing ^a   Li, Juan ^a   Fei, Qiang ^a   Sun, Yueming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Gastric cancer; Interferon induced transmembrane protein 3; Matrix metalloproteinase; Wnt catenin signaling pathway

Indexed keywords

GELATINASE A; GELATINASE B; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; IFITM3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S PHASE CELL CYCLE CHECKPOINT; STOMACH CANCER; TUMOR DIFFERENTIATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 84914706582     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3522     Document Type: Article

References (36)

1. Bertuccio P, Chatenoud L, Levi F, et al: Recent patterns in gastric cancer: a global overview. Int J Cancer 125: 666-673, 2009.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Cheng Y, Jin Z, Agarwal R, et al: LARP7 is a potential tumor suppressor gene in gastric cancer. Lab Invest 92: 1013-1019, 2012.
4. Khosravi Shahi P, Díaz Muñoz de la Espada VM, García Alfonso P, et al: Management of gastric adenocarcinoma. Clin Transl Oncol 9: 438-442, 2007.
5. Saitou M, Payer B, Lange UC, Erhardt S, Barton SC and Surani MA: Specification of germ cell fate in mice. Philos Trans R Soc Lond B Biol Sci 358: 1363-1370, 2003.
6. Lange UC, Saitou M, Western PS, Barton SC and Surani MA: The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3: 1, 2003.
7. Lewin AR, Reid LE, McMahon M, Stark GR and Kerr IM: Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199: 417-423, 1991.
8. Evans SS, Collea RP, Appenheimer MM and Gollnick SO: Interferon-α induces the expression of the L-selectin homing receptor in human B lymphoid cells. J Cell Biol 123: 1889-1898, 1993.
9. Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H and Tam PP: IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and Repulsion. Dev Cell 9: 745-756, 2005.
10. Friedman RL, Manly SP, McMahon M, Kerr IM and Stark GR: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745-755, 1984
11. Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PP and Matsui Y: Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn 230: 651-659, 2004.
12. Smith RA, Young J, Weis JJ and Weis JH: Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7: 113-121, 2006.
13. Saitou M, Barton SC and Surani MA: A molecular programme for the specification of germ cell fate in mice. Nature 418: 293-300, 2002.
14. Nibbe RK, Markowitz S, Myeroff L, Ewing R and Chance MR: Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics 8: 827-845, 2009.
15. Seyfried NT, Huysentruyt LC, Atwood JA III, Xia Q, Seyfried TN and Orlando R: Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett 263: 243-252, 2008.
16. Wylie C: IFITM1-mediated cell repulsion controls the initial steps of germ cell migration in the mouse. Dev Cell 9: 723-724, 2005.
17. Hatano H, Kudo Y, Ogawa I, et al: IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 14: 6097-6105, 2008.
18. Daniel-Carmi V, Makovitzki-Avraham E, Reuven EM, et al: The human 1-8D gene (IFITM2) is a novel p53 independent proapoptotic gene. Int J Cancer 125: 2810-2819, 2009.
19. Li J, Yang B, Zhou Q, et al: Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis 34: 1343-1351, 2013.
20. Ledford H: Cancer theory faces doubts. Nature 472: e273, 2011.
21. Gialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011.
22. Roy R, Yang J and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297, 2009.
23. Andreu P, Colnot S, Godard C, et al: Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 66: 1949-1955, 2006.
24. Tian XH, Hou WJ, Fang Y, et al: XAV939, a tankyrase 1 inhibitor, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res 32: e100, 2013.
25. Zhao B, Wang H, Zong G and Li P: The role of IFITM3 in the growth and migration of human glioma cells. BMC Neurol 13: e210, 2013.
26. Li D, Peng Z, Tang H, et al: KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res 17: 3558-3568, 2011.
27. Yang M, Gao H, Chen P, Jia J and Wu S: Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Oncol Rep 30: 171-178, 2013.
28. Kelly JM, Gilbert CS, Stark GR and Kerr IM: Differential regulation of interferon-induced mRNAs and c-myc mRNA by α- and γ-interferons. Eur J Biochem 153: 367-371, 1985
29. Jiang D, Weidner JM, Qing M, et al: Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 84: 8332-8341, 2010.
30. El-Tanani MK, Jin D, Campbell FC and Johnston PG: Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. Oncogene 29: 752-762, 2010.
31. Zhang YY, Chen B and Ding YQ: Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac J Cancer Prev 13: 2437-2444, 2012.
32. Scheel C, Eaton EN, Li SH, et al: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940, 2011.
33. Zhao Y, Guo Q, Chen J, Hu J, Wang S and Sun Y: Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation. Oncol Rep 31: 358-364, 2014.
34. Egeblad M and Werb Z: New functions for the matrix metal-loproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
35. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T and Sugimachi K: Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 6: 3581-3584, 2000.
36. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004